Related Experiment Video
Updated: Aug 15, 2026
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
[New immunoserological tests and pathogenesis for rheumatoid arthritis]
1Department of Informative Clinical Medicine, Gifu Graduate School of Medicine, Gifu 501-1194.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|September 30, 2005
Summary
Rheumatoid arthritis (RA) classification has evolved, with newer markers like MMP-3 and cytokines offering improved diagnostic potential beyond traditional rheumatoid factor (RF). Monitoring these markers aids in effective RA treatment.
Area of Science:
- Rheumatology
- Immunology
- Biochemistry
Context:
- Established Rheumatoid Arthritis (RA) classification guidelines from the American College of Rheumatology (ACR) in 1987 and Japan College of Rheumatology (JCR) in 1994.
- Traditional RA diagnosis relied on rheumatoid factor (RF) determination, which has limitations in specificity and sensitivity.
- Recent advancements in RA research have elucidated molecular mechanisms, leading to new therapeutic strategies and laboratory tests.
Purpose:
- To highlight the limitations of traditional RA diagnostic markers, specifically immunoglobulin M (IgM) rheumatoid factor (RF).
- To introduce novel diagnostic markers and their significance in the context of evolving RA understanding.
- To emphasize the importance of monitoring new biomarkers for effective RA patient management.
Summary:
- IgM rheumatoid factor (RF), a component of historical RA classification, exhibits suboptimal specificity and sensitivity.
- Emerging diagnostic tools, including cyclic citrullinated peptide-antibody rheumatoid factor (AC-RF) and matrix metalloproteinase-3 (MMP-3), show promise.
- Monitoring changes in MMP-3 and inflammatory cytokines (e.g., IL-1β, IL-2, IL-6, IL-8, IL-18) is crucial for optimizing RA treatment.
Impact:
- Improved diagnostic accuracy for Rheumatoid Arthritis (RA).
- Facilitation of early and precise RA diagnosis.
- Personalized treatment strategies for RA patients based on dynamic biomarker monitoring.
Related Concept Videos
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...